entertainment -WSS

entertainment

author：focus 2025-09-30 00:02:41 - browse：443

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter:

Novo Nordiskis conducting a large clinical trial to prove that its GLP-1 drug Wegovy, in addition to helping people lose weight, also improves cardiovascular health. The SELECT study enrolled 17,500 participants who had overweight or obesity and had preexisting heart disease. The participants were then randomized to receive weekly injections of Wegovy or a matching placebo. The primary goal is to determine the extent to which Wegovy reduces the risk of heart attacks, strokes, and heart-related deaths. Wegovy is already a blockbuster drug based on weight loss alone, but proving an additional cardiovascular benefit could open the commercial floodgates.

BridgeBiowill report in July an analysis of all-cause mortality from a clinical trial of its heart drug acoramidis. The outcome is an important, second attempt at demonstrating benefit for acoramidis in a progressive heart disease called ATTR-CM. In December 2021, the drug performed no better than a placebo on a test of how far study participants could walk over the course of six minutes, failing to achieve its primary goal. But in this second part of the same study, BridgeBio will determine if acoramidis can significantly reduce hospitalizations and death over the course of 30 months.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： What Congress can do to address the rural doctor shortage

Wikipedia

WSS

Why are Kaiser Permanente staff considering a strike?

Lasker Awards 2023: Winners in biomedical research

Biotech stock slump in 2023: awaiting the turnaround

Heart attack and stroke risk calculators need revising

The cancer drug shortage isn’t new — and neither are the solutions

Lasker Awards 2023: Winners in biomedical research

knowledge

entertainment

focus

After affirmative action ruling, medical educators look to 'holistic review'

What does generative AI mean for health care? We asked experts

DIEP, the 'gold standard' of breast reconstruction, is under threat

What Congress can do to address the rural doctor shortage

Medicare details structure of new drug price negotiation program

CDC's new outbreak response network to include Northeastern

Malaria cases in Florida and Texas: Here’s what you need to know

BioMarin wins approval for gene therapy to treat hemophilia A

The high cost of giving birth even with insurance

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wikipedia

Readout LOUD podcast: possible new ALS drug, artificial wombs

Tori Bowie and the unacceptable rates of Black maternal death

United colonoscopy coverage change 'may cost lives,' doctors say

Readout LOUD podcast: possible new ALS drug, artificial wombs

Medicare details structure of new drug price negotiation program

At least 13 dead in Texas as scorching temps continue

Wikipedia

focus

Wikipedia

Wikipedia